Castle Biosciences, Inc. logo

Castle Biosciences, Inc. (CSTL)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
24. 16
-0.07
-0.2889%
$
701.23M Market Cap
- P/E Ratio
- Div Yield
242,900 Volume
-2.14 Eps
$ 24.23
Previous Close
Analysts:
Add Transaction
Day Range
23.59 24.34
Year Range
14.59 44.28
Want to track CSTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
4 May 2026
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
4 Mar 2026
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
3 Nov 2025
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
11 Aug 2025
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
30 Apr 2025
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
26 Feb 2025
0.04
0.32
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
31 Oct 2024
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
31 Jul 2024
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
2 May 2024
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
28 Feb 2024
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
7 Jan 2024
-
-
Castle Biosciences, Inc. logo
CSTL Castle Biosciences, Inc.
2 Nov 2023
-
-

CSTL Earnings Reports FAQ

What is the earnings per share (EPS) for CSTL?

The current EPS is -2.14.

What is the company's earnings growth rate?

Castle Biosciences, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Castle Biosciences, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Castle Biosciences, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CSTL at this time, as Castle Biosciences, Inc has no recent EPS data to calculate it.